Skip to content
10-Q

Quarterly Report

CONTEXT THERAPEUTICS INC. CNTX

0001842952-25-000048

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 5, 2025 89.7M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $89.35M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $94.43M
Current Liabilities Q1 2025 · Mar 31, 2025 $1.9M
Current Liabilities Q1 2025 · Dec 31, 2024 $2.75M
Total Liabilities Q1 2025 · Mar 31, 2025 $1.98M
Total Liabilities Q1 2025 · Dec 31, 2024 $2.86M
Current Assets Q1 2025 · Mar 31, 2025 $92.73M
Current Assets Q1 2025 · Dec 31, 2024 $97.9M
Total Assets Q1 2025 · Mar 31, 2025 $92.97M
Total Assets Q1 2025 · Dec 31, 2024 $98.13M
Shares Diluted Q1 2025 · Mar 31, 2024 15.97M sh
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$4.36M
Stockholders Equity Q1 2025 · Mar 31, 2024 $8.44M
Stockholders Equity Q1 2025 · Dec 31, 2023 $11.87M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.23
Eps Basic Q1 2025 · Mar 31, 2024 −$0.23
Sga Expense Q1 2025 · Mar 31, 2024 $1.85M
Net Income Q1 2025 · Mar 31, 2024 −$3.67M
Operating Income Q1 2025 · Mar 31, 2024 −$3.82M